Tag: Policy + Advocacy Updates

The Colorado Life Science Innovation Forum is filling the Westin Westminster with interesting speakers, enlightening panelists, and Colorado’s two Lieutenant Governor candidates throughout the day tod...

Colorado Life Science Innovation Forum – Keynote Featuring Remarks by Gubernatorial Running Mates Join CBSA on September 14th at the Colorado Life Science Innovation Forum.Our keynote lunch speakers i...

Today, the August Focus newsletter was published for a more detailed look at policy, and other issues, please read Jennifer’s monthly policy update. BIOSCIENCE IN THE NEWS  Energy and Commerce Ne...

FDA releases three important initiatives for medical device development, innovation and safety The FDA announced it is taking steps to advance innovation and surveillance for medical devices through t...

FDA Releases New Draft Guidance to advance and modernize oncology drug trials In the FDA’s ongoing effort to modernize and create a more efficient approval process, last Friday the FDA released their...

FDA Receives Funding in Senate Passed Appropriations Bill Last week the U.S. Senate overwhelmingly passed a $154.2 billion spending bill that includes more than $3 billion for the FDA. When industry f...

  Scott Larson, VP, Legal and General Counsel, Terumo BCT; Jenna Hutchins, Territory Manager, ResMed; Congresswoman Dianna Degette; April Giles, President, CBSA; Jonathan Toronto, Vice President,...

On behalf of Colorado BioScience Association thank you for your efforts to secure a yes vote on H.R. 184 - Protect Medical Innovation Act of 2017. We appreciate the time you took to advocate to your r...

This has been another week with persistent advocacy for full repeal of the Medical device tax in standalone legislation. A permanent repeal of the medical device excise tax remains a top priority for...

CBSA continues to advocate for a full repeal of the Medical device tax in standalone legislation. A permanent repeal of the tax remains a top priority for CBSA and Colorado's medtech innovators. While...